Literature DB >> 6328332

[3H]5'-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum.

S M Yeung, R D Green.   

Abstract

Adenosine analogs such as 5'-N- ethylcarboxamide adenosine and N6-cyclohexyladenosine stimulate or inhibit adenosine cyclase activity in preparations of rat striatum depending on the assay conditions. N6-cyclohexyladenosine inhibits but does not stimulate adenosine cyclase activity in preparations of hippocampus. These findings suggest that the striatum contains both Ra (stimulatory) and Ri (inhibitory) adenosine receptors while the hippocampus contains only Ri receptors. We have previously shown that [3H]N6-cyclohexyladenosine binds to Ri receptors in rat hippocampus ( Yeung and Green 1983). Comparisons of the characteristics of [3H]5'-N- ethylcarboxamide adenosine and [3H]N6-cyclohexyladenosine binding to hippocampus show that [3H]5'-N- ethylcarboxamide adenosine also binds to Ri receptors with high affinity. [3H]5'-N- ethylcarboxamide adenosine binds to Ri receptors in the striatum and to a second site that is present in striatum but not hippocampus. High affinity binding of both ligands to Ri receptors can be blocked by treatments with N-ethylmaleimide that do not markedly affect [3H]5'-N- ethylcarboxamide adenosine binding to the second site in the striatum. The pharmacological characteristics of the second site indicate that it is the Ra adenosine receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328332     DOI: 10.1007/bf00495947

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupled beta-adrenergic receptors.

Authors:  J M Stadel; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

2.  Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation.

Authors:  D H Jones; A I Matus
Journal:  Biochim Biophys Acta       Date:  1974-08-09

Review 3.  Bimodal regulation of adenylate cyclase.

Authors:  D M Cooper
Journal:  FEBS Lett       Date:  1982-02-22       Impact factor: 4.124

4.  Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution.

Authors:  J Prémont; M Perez; G Blanc; J P Tassin; A M Thierry; D Hervé; J Bockaert
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

5.  Adenosine receptors in fat cells. Identification by (-)-N6-[3H]phenylisopropyladenosine binding.

Authors:  T Trost; U Schwabe
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

6.  Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists.

Authors:  R F Bruns
Journal:  Can J Physiol Pharmacol       Date:  1980-06       Impact factor: 2.273

7.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

8.  Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide.

Authors:  S M Yeung; R D Green
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

9.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Neuronal location of N6-cyclohexyl[3H]adenosine binding sites in rat and guinea-pig brain.

Authors:  T F Murray; D L Cheney
Journal:  Neuropharmacology       Date:  1982-06       Impact factor: 5.250

View more
  22 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Autoradiographic localization of mouse brain adenosine receptors with an antagonist ([3H]xanthine amine congener) ligand probe.

Authors:  J Deckert; P F Morgan; J C Bisserbe; K A Jacobson; K L Kirk; J W Daly; P J Marangos
Journal:  Neurosci Lett       Date:  1988-03-31       Impact factor: 3.046

3.  Target size of the adenosine Ri receptor.

Authors:  L T Frame; S M Yeung; J C Venter; D M Cooper
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

4.  Endogenous adenosine as a modulator of hippocampal acetylcholine release.

Authors:  R Jackisch; H Strittmatter; L Kasakov; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

5.  Qualitative differences in the effects of adenosine analogs on the cholinergic systems of rat striatum and hippocampus.

Authors:  G L Forloni; G Fisone; S Consolo; H Ladinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

6.  Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.

Authors:  S F Stewart; T A Pugsley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

7.  A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets.

Authors:  D Ukena; K A Jacobson; K L Kirk; J W Daly
Journal:  FEBS Lett       Date:  1986-04-21       Impact factor: 4.124

8.  [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.

Authors:  K A Jacobson; D Ukena; K L Kirk; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Quantitative [3H]dipyridamole autoradiography: evidence for adenosine transporter heterogeneity in guinea pig brain.

Authors:  J Deckert; J C Bisserbe; P J Marangos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

10.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.